Syncom Formulations (India) Limited (BOM:524470)

BOM:524470 Revenue

Syncom Formulations (India) had revenue of 1.26B INR in the quarter ending June 30, 2026, with 7.38% growth. This brings the company's total for the last twelve months to 4.98B, up 0.63% year-over-year. In the fiscal year ending March 31, 2026, Syncom Formulations (India) had annual revenue of 4.89B with 5.20% growth. That makes Syncom Formulations (India) the 27,543rd largest company in the world by revenue and 1,821st in India.

• Revenue (ttm): 4.98B
• Revenue Growth: +0.63%
• P/S Ratio: 3.81
• Revenue / Employee: 5.52M
• Employees: 902
• Market Cap: 18.97B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceuticals Drugs & Formulations 5.16B 99.1%
• Renting of Property 36.77M 0.7%
• Trading of Commodities 11.00M 0.2%

By Geography

Chart

• Export 4.12B 84.3%
• India 695.58M 14.2%
• Unallocated 74.82M 1.5%

Fiscal year ended Mar 31, 2026 See the full BOM:524470 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	4.89B	241.59M	5.20%
Mar 31, 2025	4.65B	2.02B	76.55%
Mar 31, 2024	2.63B	391.33M	17.45%
Mar 31, 2023	2.24B	45.91M	2.09%
Mar 31, 2022	2.20B	-251.42M	-10.27%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error